Acute coagulopathy and inflammation of trauma

Acute coagulopathy and inflammation of trauma - ACIT trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39604

Enrollment

500

Registered

2012-01-17

Start date

2012-04-18

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

clotting disorder coagulopathy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Trauma patients for whom a full trauma team activation is given

Exclusion criteria

Exclusion criteria: * Age 5% of their body surface area * Patients taking anticoagulant medication other than aspirin (

Design outcomes

Primary

Measure	Time frame
Primary endpoint: 28 day mortality	—

Secondary

Measure	Time frame
Secondary endpoints: Blood transfusion requirement in first 24 hours, length of hospital stay, ICU stay, 28-day ventilator free days, occurrence of acute lung injury (ALI), acute respiratory distress syndrome (ARDS), acute kidney injury (AKI) and multiple organ failure (MOF)	—

Countries

Netherlands

Outcome results